Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€32.78

€32.78

1.170%
0.38
1.170%
€35.00
 
20:54 / Tradegate WKN: 880105 / Symbol: DBSDF / Name: DBS / Stock / Banking Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

DBS Group Holdings Stock

DBS Group Holdings gained 1.170% today.
The community is currently still undecided about DBS Group Holdings with 1 Buy predictions and 0 Sell predictions.
As a result the target price of 35 € shows a slightly positive potential of 6.77% compared to the current price of 32.78 € for DBS Group Holdings.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for DBS Group Holdings stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of DBS Group Holdings in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of DBS Group Holdings vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
DBS Group Holdings 1.170% -1.788% 7.178% 40.625% 4.753% 38.758% 167.327%
Oversea-Chinese Banking Corp. Ltd. 0.090% 0.000% 3.818% 18.958% -2.435% 31.264% 115.472%
United Overseas Bank -1.290% -0.443% 1.811% 19.690% -4.626% 24.823% 106.167%
Citigroup Inc. -0.320% -3.349% 6.091% 54.062% 17.086% 55.823% 83.715%

Comments

Buy DBS Group Holdings
Show more

News

Why Novo Nordisk Stock Dropped Today
Why Novo Nordisk Stock Dropped Today

Novo Nordisk (NYSE: NVO), the Danish drugmaker of GLP-1 weight loss drugs Ozempic and Wegovy, slipped 2% through 10:30 a.m. ET Friday after suffering a one-two punch from Reuters and a bank analyst.